Incyte Клинические исследования

Клинические исследования компании Incyte: фазы, заболевания и опубликованные результаты.

• A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
  Фаза 3 · Atopic Dermatitis · Завершено · 29.06.2023
• Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cance
  Фаза 2 · Inflammatory Breast Cancer · Завершено · 18.04.2024
• A Study of Baricitinib in Participants With Rheumatoid Arthritis
  Фаза 4 · Rheumatoid Arthritis · Завершено · 10.07.2026
• Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Di
  Фаза 2 · Non-sclerotic Cutaneous Chronic Graft-versus-host Disease · Идёт, набор закрыт · 10.02.2026
• Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.
  Фаза 2 · Myelofibrosis · Завершено · 9.07.2026
• Ruxolitinib for Cancer Cachexia
  Ранняя фаза 1 · Stage IV Non-small Cell Lung Cancer · Идёт, набор закрыт · 7.07.2026
• Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer
  Фаза 3 · Metastatic Squamous Non-Small Cell Lung Cancer · Завершено · 6.02.2025
• Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
  Фаза 2 · Chronic Myelomonocytic Leukemia · Идёт, набор закрыт · 17.10.2023
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
  Фаза 4 · Rheumatoid Arthritis · Завершено · 24.06.2026
• Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma
  Фаза 2 · Glioblastoma · Идёт, набор закрыт · 15.09.2023
• A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
  Фаза 1/2 · Advanced Solid Tumors · Прекращено · 4.06.2026
• A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermati
  Фаза 3 · Atopic Dermatitis · Завершено · 22.05.2026
• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
  Фаза 3 · Renal Cell Carcinoma · Завершено · 10.09.2019
• INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to
  Фаза 1/2 · Anemia · Идёт, набор закрыт · 12.05.2026
• Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
  Фаза 2 · Hidradenitis Suppurativa · Прекращено · 28.04.2026

Исследования по компаниям

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & JohnsonBristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

Все исследования